Efficacy and safety of bortezomib combined with cyclophosphamide or lenalidomide for the treatment of patients with multiple myeloma who are not suitable for transplantation

doi:10.3969/j.issn.1672-3384.2025.07.009

Lingyun XU, Chen LI

Clinical Medication Journal ›› 2025, Vol. 23 ›› Issue (7) : 51-56.

PDF(969 KB)

Clinical Medication Journal ›› 2025, Vol. 23 ›› Issue (7) : 51-56. DOI: 10.3969/j.issn.1672-3384.2025.07.009

Original Article

Efficacy and safety of bortezomib combined with cyclophosphamide or lenalidomide for the treatment of patients with multiple myeloma who are not suitable for transplantation

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2025, 23(7): 51-56 https://doi.org/10.3969/j.issn.1672-3384.2025.07.009

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(969 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2025-04-01	2025-07-10
Issue Date
2025-07-29

Please choose a citation manager

Content to export